US Stock Market Response to FDA Approval of New Dermatologic Drugs
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Drugs in Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
United States Stock Market Response to FDA Approval of New Dermatologic Drugs
J Drugs Dermatol 2020 Jun 01;19(6)639-645, RS Mazmudar, R Tripathi, HH Ezaldein, JF ScottFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.